AMY KUBLER: Open Payments
NPI 1841712957 · PENN LAIRD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 13 payments from 6 companies in 2025. Trend: 2023 $658 · 2024 $965 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $24 |
Products named: VRAYLAR, REXULTI, FARXIGA, QULIPTA, Auvelity, OTEZLA, ZEPBOUND, MOUNJARO.
Industry payments across VA — which companies pay providers there.
